OUR PRODUCTS

MOBILE APPS

GENERAL INFO

RGEN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Repligen (RGEN) Earnings Date & Reports

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RGEN is expected to report earnings to rise 12.27% to 41 cents per share on November 04

Q3'25

Est.

$0.42

Q2'25

Missed

by $0.02

Q1'25

Beat

by $0.04

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.10

The last earnings report on July 29 showed earnings per share of 37 cents, missing the estimate of 38 cents. With 1.12M shares outstanding, the current market capitalization sits at 6.87B.

View a ticker or compare two or three

Compare

RGEN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RGEN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RGEN showed earnings on July 29, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of biologic drugs

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Biotechnology

Address

41 Seyon Street

Phone

+1 781 250-0111

Employees

1783

Web

https://www.repligen.com